This article was originally published here
Pediatr Neurol. 2021, April 2; 120: 7-10. doi: 10.1016 / j.pediatrneurol.2021.03.007. Online before printing.
ABSTRACT
BACKGROUND: Tuberous...
RED BANK, NJ, April 27, 2021 / PRNewswire / - Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company devoted to catching and preventing immune-mediated...